Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.14309/ajg.0000000000000732 http://scihub22266oqcxt.onion/10.14309/ajg.0000000000000732 32496339!7288768!32496339     free     free     free       Am+J+Gastroenterol 2020 ; 115 (8): 1286-1288 Nephropedia Template TP {{tp|p=32496339|t=2020. Lipase Elevation in Patients With COVID-19 |pdf=|usr=}}{{32496339}} gab.com Text Lipase Elevation in Patients With COVID-19 JO: Am J Gastroenterol http://www.kidney.de/pget.php?&tw=1&pmid=32496339 #FOAvip INTRODUCTION: Although coronavirus disease (COVID-19) has been associated with gastrointestinal manifestations, its effect on the pancreas remains unclear. We aimed to assess the frequency and characteristics of hyperlipasemia in patients with COVID-19. METHODS: A retrospective cohort study of hospitalized patients across 6 US centers with COVID-19. RESULTS: Of 71 patients, 9 (12.1%) developed hyperlipasemia, with 2 (2.8%) greater than 3 times upper limit of normal. No patient developed acute pancreatitis. Hyperlipasemia was not associated with poor outcomes or symptoms. DISCUSSION: Although a mild elevation in serum lipase was observed in some patients with COVID-19, clinical acute pancreatitis was not seen. Twit Text FOAVip Lipase Elevation in Patients With COVID-19 ????Am J Gastroenterol http://www.kidney.de/pget.php?&tw=1&pmid=32496339 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32496339 #FOAvip English Wikipedia <ref>{{Cite pmid|32496339}}</ref> Lipase Elevation in Patients With COVID-19 #MMPMID32496339 McNabb-Baltar J; Jin DX; Grover AS; Redd WD; Zhou JC; Hathorn KE; McCarty TR; Bazarbashi AN; Shen L; Chan WW Am J Gastroenterol 2020[Aug]; 115 (8): 1286-1288 PMID32496339show ga INTRODUCTION: Although coronavirus disease (COVID-19) has been associated with gastrointestinal manifestations, its effect on the pancreas remains unclear. We aimed to assess the frequency and characteristics of hyperlipasemia in patients with COVID-19. METHODS: A retrospective cohort study of hospitalized patients across 6 US centers with COVID-19. RESULTS: Of 71 patients, 9 (12.1%) developed hyperlipasemia, with 2 (2.8%) greater than 3 times upper limit of normal. No patient developed acute pancreatitis. Hyperlipasemia was not associated with poor outcomes or symptoms. DISCUSSION: Although a mild elevation in serum lipase was observed in some patients with COVID-19, clinical acute pancreatitis was not seen. |Abdominal Pain/epidemiology[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Anorexia/epidemiology[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Cohort Studies[MESH] |Coronavirus Infections/blood/*epidemiology[MESH] |Diarrhea/epidemiology[MESH] |Female[MESH] |Humans[MESH] |Lipase/*blood[MESH] |Male[MESH] |Middle Aged[MESH] |Nausea/epidemiology[MESH] |Pancreatitis/blood/diagnostic imaging/*epidemiology[MESH] |Pandemics[MESH] |Pneumonia, Viral/blood/*epidemiology[MESH] |Retrospective Studies[MESH] |SARS-CoV-2[MESH] |Tomography, X-Ray Computed[MESH] |United States/epidemiology[MESH]Lipase Elevation in Patients With COVID-19 (epmc).pdf DeepDyve Pubget Overpricing